Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This is a multicenter study to test the hypothesis that telcagepant is superior to placebo in preventing perimenstrual migraines as measured by mean monthly headaches during the entire treatment period. This study will also evaluate the safety and tolerability of telcagepant for female migraine participants.
Epistemonikos ID: 132ca36039ad24eed17cc0826df7a9bd4404f15b
First added on: May 05, 2024